We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and p... Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Show more
TN-201 Well Tolerated at 3E13 vg/kg Dose AAV9 Capsid Demonstrated Robust Delivery of TN-201 Transgene to Heart Muscle Cells Resulting in Increasing RNA Expression and an Increase in Protein...
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
TN-401 AAV9-based Gene Therapy Designed to Deliver Fully Functional PKP2 Gene with the Aim of Increasing Protein Levels to Address Underlying Disease RIDGE-1 Currently Enrolling at Six Centers;...
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0099 | -0.692307692308 | 1.43 | 1.63 | 1.395 | 2641275 | 1.48615087 | CS |
4 | -1.4499 | -50.5191637631 | 2.87 | 2.945 | 0.9867 | 6703477 | 1.53487902 | CS |
12 | -0.7899 | -35.742081448 | 2.21 | 4.01 | 0.9867 | 5298192 | 2.25727402 | CS |
26 | -1.5499 | -52.1851851852 | 2.97 | 4.06 | 0.9867 | 2583923 | 2.273659 | CS |
52 | -1.6999 | -54.483974359 | 3.12 | 7.01 | 0.9867 | 1553302 | 2.63172064 | CS |
156 | -12.1199 | -89.511816839 | 13.54 | 16.1699 | 0.9867 | 725105 | 3.22883921 | CS |
260 | -18.0799 | -92.7174358974 | 19.5 | 32 | 0.9867 | 654561 | 3.86370365 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions